首页> 外文期刊>European Journal of Pharmacology: An International Journal >Mechanism of hyperhomocysteinemia-induced vascular endothelium dysfunction - Possible dysregulation of phosphatidylinositol-3-kinase and its downstream phosphoinositide dependent kinase and protein kinase B
【24h】

Mechanism of hyperhomocysteinemia-induced vascular endothelium dysfunction - Possible dysregulation of phosphatidylinositol-3-kinase and its downstream phosphoinositide dependent kinase and protein kinase B

机译:高同型半胱氨酸血症引起的血管内皮功能障碍的机制-磷脂酰肌醇3激酶及其下游磷酸肌醇依赖性激酶和蛋白激酶B可能失调

获取原文
获取原文并翻译 | 示例
           

摘要

Imbalance of l-arginine/endothelial nitric oxide synthatase (eNOS) activity is the hallmark of vascular endothelium dysfunction. Hyperhomocysteinemia (Hhy) has been identified as a potential risk factor for vascular endothelium dysfunction that leads to cardiovascular disorders. Phosphatidylinositol-3 kinase (PI3K) is a ubiquitous enzyme involved in plethora of cell signaling including the endothelial cells and it has been reported that signaling through this enzyme and its downstream pathway viz phosphoinositide-dependent kinase (PDK)/protein kinase B (Akt) and eNOS is impaired in diseased conditions. Thus present study was designed to investigate the role of PI3K and PDK/Akt in vascular endothelium dysfunction produced by Hhy. Hhy was produced by administering l-methionine (1.7%w/w, p.o). After four weeks of l-methionine administration, vascular endothelium dysfunction was assessed in terms of attenuation of acetylcholine-induced endothelium dependent relaxation (Isolated aortic ring preparation), a decrease in serum nitrite level, mRNA expression of eNOS (rtPCR) and disruption of integrity of vascular endothelium (Electron microscopy). Administration of insulin (0.6 IU/kg/day, s.c), YS-49 (1.6 mg/kg/day, i.p), DAQB1 (5 mg/kg/day, i.p) and atorvastatin (30 mg/kg/day, p.o) significantly improved acetylcholine-induced endothelium-dependent relaxation, serum nitrateitrite level, mRNA expression of eNOS and integrity of vascular endothelium. This ameliorative effect of insulin was blocked by wortmannin (inhibitor of PI3K), UCN-01(PDK inhibitor), API-2 (Akt inhibitor) and l-NAME (eNOS inhibitor). Thus, it may be concluded that activation of PI3K and its downstream pathways viz. PDK/Akt and eNOS improve Hhy-induced vascular endothelium dysfunction and that therapeutic interventions designed for these pathways may provide potential therapeutic strategies to combat vascular complications.
机译:l-精氨酸/内皮型一氧化氮合酶(eNOS)活性的失衡是血管内皮功能障碍的标志。高同型半胱氨酸血症(Hhy)已被确定为导致心血管疾病的血管内皮功能障碍的潜在危险因素。磷脂酰肌醇3激酶(PI3K)是一种普遍存在的酶,参与包括内皮细胞在内的大量细胞信号传导,据报道通过该酶及其下游途径的信号传导即磷酸肌醇依赖性激酶(PDK)/蛋白激酶B(Akt)而eNOS在疾病条件下受损。因此,本研究旨在研究PI3K和PDK / Akt在Hhy产生的血​​管内皮功能障碍中的作用。通过施用L-甲硫氨酸(1.7%w / w,p.o)产生了Hhy。服用L-蛋氨酸四周后,根据乙酰胆碱诱导的内皮依赖性舒张功能减弱(分离的主动脉环制备),血清亚硝酸盐水平降低,eNOS的mRNA表达(rtPCR)和完整性破坏来评估血管内皮功能障碍血管内皮细胞(电子显微镜)。给予胰岛素(0.6 IU / kg /天,皮下注射),YS-49(1.6 mg / kg /天,腹腔注射),DAQB1(5 mg / kg /天,腹腔注射)和阿托伐他汀(30 mg / kg /天,口服) )显着改善了乙酰胆碱诱导的内皮依赖性舒张,血清硝酸盐/亚硝酸盐水平,eNOS的mRNA表达和血管内皮的完整性。胰岛素的这种改善作用被渥曼青霉素(PI3K抑制剂),UCN-01(PDK抑制剂),API-2(Akt抑制剂)和l-NAME(eNOS抑制剂)阻断。因此,可以得出结论,PI3K及其下游途径的激活即是。 PDK / Akt和eNOS改善了Hhy引起的血管内皮功能障碍,针对这些途径设计的治疗性干预措施可能为对抗血管并发症提供潜在的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号